Status:
COMPLETED
A Cross-Functional, Population-Representative, Web-Based, Epidemiologic Study to Estimate the Prevalence and Burden of Nocturia Due to Nocturnal Polyuria in the US
Lead Sponsor:
Ferring Pharmaceuticals
Conditions:
Nocturnal Polyuria
Eligibility:
All Genders
30+ years
Brief Summary
To estimate the prevalence of nocturia due to nocturnal polyuria (NP) in the US and describe the demographic and clinical characteristics as well as the burden of illness in participants with nocturia...
Eligibility Criteria
Inclusion
- At least 30 years of age;
- Willing to provide informed consent;
- Able to read US-English or Spanish
- Able to use a computer and access the internet.
Exclusion
- Symptomatic acute urinary tract infection (UTI) (experiencing symptoms such as pain or burning when you urinate, strong and frequent urge to urinate, or cloudy, bloody, or strong-smelling urine);
- Currently pregnant or ≤12 months postpartum;
- Recent surgery in the last \<6 months;
- Current lifestyle that leads to irregular or atypical circadian patterns (e.g. employed in overnight shift work)
- Prior YouGov survey participation in past two weeks
Key Trial Info
Start Date :
July 22 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
10190 Patients enrolled
Trial Details
Trial ID
NCT04125186
Start Date
July 22 2019
End Date
June 30 2020
Last Update
March 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Evidera Inc.
Seattle, Washington, United States, 98101